Skip to content
Home/Companies/Healthcare/Resistomap
Resistomap

Resistomap

Healthcare·Finland·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns Resistomap?

Resistomap is currently owned by Ananda Impact Ventures through Ananda Impact Fund IV (2022 vintage), since 2023.

Hand-verified · updated 2026-07-03

Ananda Impact Ventures
Investor
Ananda Impact Ventures
Ananda Impact Fund IV · 2022 · Impact

Key facts

HQFinland
SectorHealthcare
StatusActive
Websitewww.resistomap.com

More from Ananda Impact Fund IV

Other portfolio companies in the same fund.

Jua
Active
AI/MLSwitzerland· 2025
Mycolever
Active
IndustrialsGermany· 2025
Nordic Salt Cycle
Active
IndustrialsDenmark· 2025
Pheiron
Pheiron
Active
BiotechGermany· 2025
Pulsetrain
Active
ClimateTechGermany· 2025
Decade
Active
ClimateTechGermany· 2024

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Track Resistomap

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Resistomap?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Resistomap.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue